JeffreyAKnipsteinMD
Pediatric Hematology & Oncology • Nashville, TNPediatric Neuro-Oncology
Medical Director, Servier Pharmaceuticals
Dr. Knipstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Private
Nashville, TN 37221
Education & Training
University of ColoradoFellowship, Pediatric Neuro-Oncology, 2011 - 2012- University of ColoradoFellowship, Pediatric Hematology/Oncology, 2007 - 2010
University of MichiganResidency, Pediatrics, 2004 - 2007
Washington University in St. Louis School of MedicineClass of 2004
Certifications & Licensure
TN State Medical License 2020 - 2025
WI State Medical License 2015 - 2021
DC State Medical License 2012 - 2016
VA State Medical License 2012 - 2016
CO State Medical License 2008 - 2013
MI State Medical License 2004 - 2007- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 16 citationsTargetable BRAF and RAF1 Alterations in Advanced Pediatric CancersAndrew Rankin, Adrienne Johnson, Alison Roos, Geoffrey Kannan, Jeffrey Knipstein
The Oncologist. 2021-01-01 - 21 citationsEntinostat augments NK cell functions via epigenetic upregulation of IFIT1-STING-STAT4 pathway.John M Idso, Shunhua Lao, Nathan J. Schloemer, Jeffrey Knipstein, Robert Burns
Oncotarget. 2020-05-19 - 65 citationsGenomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.Anirban Das, Sumedha Sudhaman, Daniel Morgenstern, Ailish Coblentz, Jiil Chung
Nature Medicine. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
